uric acid has been researched along with Polycystic Ovarian Syndrome in 23 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Serum uric acid levels were measured in 40 polycystic ovary syndrome (PCOS) patients and 40 non-hyperandrogenic women matched for BMI and grade of obesity, and were followed-up in 34 PCOS patients who were randomized to an oral contraceptive containing 35 mg ethinyl-estradiol plus 2 mg cyproterone acetate (Diane(35) Diario) or metformin (850 mg twice daily) for 24 weeks." | 9.13 | Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin. ( Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Uriol Rivera, MG, 2008) |
| "Serum uric acid levels are elevated in polycystic ovary syndrome, however, the relationship between serum uric acid level and reproductive outcomes in women with polycystic ovary syndrome remains unclear." | 8.31 | Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study. ( Chen, Y; Ding, L; Li, Y; Liu, C; Mu, L; Teng, Y; Wang, G; Xu, Z; Yang, H; Ye, Z; Zhao, Y, 2023) |
| "To investigate the relationship between fibrinogen-like protein 1 (FGL-1) concentrations and various metabolic characteristics in patients with polycystic ovary syndrome (PCOS) and explore whether FGL-1 could be a predictive biomarker for PCOS." | 8.12 | Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study. ( Cai, M; Chen, D; Dilimulati, D; Gao, X; Qu, S; Shao, X; Sun, H; You, H; Zhang, M; Zhang, Y, 2022) |
| "This study aims to investigate the correlation between serum uric acid levels and body fat distribution in patients with polycystic ovary syndrome (PCOS)." | 8.02 | Correlation Between Serum Uric Acid and Body Fat Distribution in Patients With Polycystic Ovary Syndrome. ( Cai, M; Cui, R; Dilimulati, D; Fei, H; Gao, X; Lin, Z; Qu, S; Shao, X; Sun, H; Zeng, Q; Zhang, M; Zhang, Y, 2021) |
| "At the beginning of the study, both treatment arms differed in the degree of insulin resistance, calculated bioavailable testosterone, as well as in plasma levels of dehydroepiandrosterone sulfate, uric acid, hsCRP and 25-hydroxyvitamin D." | 8.02 | The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome. ( Krysiak, R; Okopień, B; Szkróbka, W, 2021) |
| " Following a low-calorie diet with a lower glycemic index is proposed to silence inflammation by increasing the concentration of uric acid." | 7.91 | A Low Glycemic Index Decreases Inflammation by Increasing the Concentration of Uric Acid and the Activity of Glutathione Peroxidase (GPx3) in Patients with Polycystic Ovary Syndrome (PCOS). ( Drozd, R; Szczuko, M; Zapalowska-Chwyć, M, 2019) |
| "Recently, an inverse correlation between serum uric acid concentrations and insulin sensitivity has been described in subjects with varying degrees of metabolic syndrome, suggesting that measurement of serum uric acid may provide a simple marker of insulin resistance." | 7.69 | Normal serum uric acid concentrations in women with polycystic ovary syndrome. ( Anttila, L; Irjala, K; Penttilä, T; Rouru, J, 1996) |
| "Spironolactone (SPL) is a mineralocorticoid receptor (MR) blocker that has been in wide clinical use for some decades." | 5.56 | Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid-a familiar foe. ( Adeyanju, OA; Agbana, RD; Falodun, TO; Michael, OS; Oyewole, AL; Soetan, OA, 2020) |
| "Serum uric acid levels were measured in 40 polycystic ovary syndrome (PCOS) patients and 40 non-hyperandrogenic women matched for BMI and grade of obesity, and were followed-up in 34 PCOS patients who were randomized to an oral contraceptive containing 35 mg ethinyl-estradiol plus 2 mg cyproterone acetate (Diane(35) Diario) or metformin (850 mg twice daily) for 24 weeks." | 5.13 | Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin. ( Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Uriol Rivera, MG, 2008) |
| " Apart from the diagnostic criteria, MetS has also been associated with other risk factors including waist to hip ratio, high density lipoprotein dysfunction, small dense low density lipoprotein, postprandial hypertriglyceridaemia, lipoprotein (a), uric acid, liver function tests, prothrombotic factors, cytokines, adipokines, vitamin D, arterial stiffness, renal dysfunction, nephrolithiasis, polycystic ovary syndrome, obstructive sleep apnea." | 4.90 | Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. ( Athyros, VG; Karagiannis, A; Katsiki, N; Mikhailidis, DP, 2014) |
| "Serum uric acid levels are elevated in polycystic ovary syndrome, however, the relationship between serum uric acid level and reproductive outcomes in women with polycystic ovary syndrome remains unclear." | 4.31 | Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study. ( Chen, Y; Ding, L; Li, Y; Liu, C; Mu, L; Teng, Y; Wang, G; Xu, Z; Yang, H; Ye, Z; Zhao, Y, 2023) |
| "To investigate the relationship between fibrinogen-like protein 1 (FGL-1) concentrations and various metabolic characteristics in patients with polycystic ovary syndrome (PCOS) and explore whether FGL-1 could be a predictive biomarker for PCOS." | 4.12 | Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study. ( Cai, M; Chen, D; Dilimulati, D; Gao, X; Qu, S; Shao, X; Sun, H; You, H; Zhang, M; Zhang, Y, 2022) |
| " Hyperuricemia was defined as serum uric acid level of at least 357 μmol/L." | 4.02 | Neck Circumference Is Associated With Hyperuricemia in Women With Polycystic Ovary Syndrome. ( Ding, L; Jin, C; Liu, C; Mu, L; Yang, H; Yu, R, 2021) |
| "This study aims to investigate the correlation between serum uric acid levels and body fat distribution in patients with polycystic ovary syndrome (PCOS)." | 4.02 | Correlation Between Serum Uric Acid and Body Fat Distribution in Patients With Polycystic Ovary Syndrome. ( Cai, M; Cui, R; Dilimulati, D; Fei, H; Gao, X; Lin, Z; Qu, S; Shao, X; Sun, H; Zeng, Q; Zhang, M; Zhang, Y, 2021) |
| "At the beginning of the study, both treatment arms differed in the degree of insulin resistance, calculated bioavailable testosterone, as well as in plasma levels of dehydroepiandrosterone sulfate, uric acid, hsCRP and 25-hydroxyvitamin D." | 4.02 | The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome. ( Krysiak, R; Okopień, B; Szkróbka, W, 2021) |
| "In a multi-center study (n=2495), we used unsupervised machine learning to cluster patients with obesity from Shanghai Tenth People's hospital (n=882, main cohort) based on three clinical variables (AUCs of glucose and of insulin during OGTT, and uric acid)." | 4.02 | Machine Learning to Identify Metabolic Subtypes of Obesity: A Multi-Center Study. ( Arefan, D; Cheng, X; Du, L; Feng, W; Gao, L; Lin, Z; Liu, Y; Ma, C; Qu, S; Wu, S; You, H; Yu, J; Zhou, D; Zhu, D; Zhu, J, 2021) |
| " Following a low-calorie diet with a lower glycemic index is proposed to silence inflammation by increasing the concentration of uric acid." | 3.91 | A Low Glycemic Index Decreases Inflammation by Increasing the Concentration of Uric Acid and the Activity of Glutathione Peroxidase (GPx3) in Patients with Polycystic Ovary Syndrome (PCOS). ( Drozd, R; Szczuko, M; Zapalowska-Chwyć, M, 2019) |
| "The serum uric acid (SUA) level and the prevalence of hyperuricemia markedly increased in women with PCOS." | 3.88 | Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome. ( Chen, Q; Chen, X; Chen, Y; Huang, X; Mu, L; Pan, J; Tang, R; Teng, Y; Wang, P; Yang, H; Yang, L, 2018) |
| "Studies have suggested that the Calpain-10 gene polymorphisms may play a role in polycystic ovary syndrome (PCOS) susceptibility." | 3.74 | Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women. ( Márquez, JL; Pacheco, A; Salazar, LA; Valdés, P, 2008) |
| "Recently, an inverse correlation between serum uric acid concentrations and insulin sensitivity has been described in subjects with varying degrees of metabolic syndrome, suggesting that measurement of serum uric acid may provide a simple marker of insulin resistance." | 3.69 | Normal serum uric acid concentrations in women with polycystic ovary syndrome. ( Anttila, L; Irjala, K; Penttilä, T; Rouru, J, 1996) |
| "Insulin resistance was calculated using homeostasis assessment model (HOMA-IR)." | 2.76 | Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress. ( Bjekic-Macut, J; Bozic, I; Damjanovic, S; Djukic, T; Lissounov, A; Macut, D; Matic, M; Petakov, M; Pljesa-Ercegovac, M; Savic-Radojevic, A; Simic, T; Suvakov, S, 2011) |
| "Spironolactone (SPL) is a mineralocorticoid receptor (MR) blocker that has been in wide clinical use for some decades." | 1.56 | Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid-a familiar foe. ( Adeyanju, OA; Agbana, RD; Falodun, TO; Michael, OS; Oyewole, AL; Soetan, OA, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 16 (69.57) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, H | 6 |
| Liu, C | 5 |
| Jin, C | 1 |
| Yu, R | 1 |
| Ding, L | 4 |
| Mu, L | 6 |
| Zhang, Y | 2 |
| Cai, M | 2 |
| Dilimulati, D | 2 |
| Lin, Z | 2 |
| Sun, H | 2 |
| Cui, R | 1 |
| Fei, H | 1 |
| Gao, X | 2 |
| Zeng, Q | 1 |
| Shao, X | 2 |
| Zhang, M | 2 |
| Qu, S | 3 |
| Yang, M | 1 |
| Bai, W | 1 |
| Jiang, B | 1 |
| Wang, Z | 1 |
| Wang, X | 1 |
| Sun, Y | 1 |
| Liu, F | 1 |
| Cui, G | 1 |
| Song, X | 1 |
| Li, J | 1 |
| Wu, F | 1 |
| Chen, D | 1 |
| You, H | 2 |
| Liu, K | 1 |
| Zhao, X | 1 |
| Zhu, J | 2 |
| Liu, Y | 2 |
| Hao, L | 1 |
| Gao, Y | 1 |
| Liu, P | 1 |
| Zheng, X | 1 |
| Ma, J | 1 |
| Hu, M | 1 |
| Long, J | 1 |
| Wei, Q | 1 |
| Ren, W | 1 |
| Wang, G | 3 |
| Li, Y | 3 |
| Chen, Y | 4 |
| Teng, Y | 4 |
| Xu, Z | 3 |
| Ye, Z | 3 |
| Zhao, Y | 3 |
| El-Eshmawy, MM | 2 |
| Ibrahim, A | 2 |
| Bahriz, R | 2 |
| Shams-Eldin, N | 2 |
| Mahsoub, N | 2 |
| Krysiak, R | 3 |
| Kowalcze, K | 2 |
| Okopień, B | 3 |
| Oktanella, Y | 1 |
| Untari, H | 1 |
| Wuragil, DK | 1 |
| Ismiawati, H | 1 |
| Hasanah, NA | 1 |
| Agustina, GC | 1 |
| Pratama, DAO | 1 |
| Adeyanju, OA | 1 |
| Falodun, TO | 1 |
| Michael, OS | 1 |
| Soetan, OA | 1 |
| Oyewole, AL | 1 |
| Agbana, RD | 1 |
| Szkróbka, W | 1 |
| Liu, YN | 1 |
| Luo, H | 1 |
| Che, X | 1 |
| Peng, H | 1 |
| Li, M | 1 |
| Liu, KX | 1 |
| Hu, J | 1 |
| Xu, W | 1 |
| Feng, W | 1 |
| Ma, C | 1 |
| Arefan, D | 1 |
| Zhou, D | 1 |
| Cheng, X | 1 |
| Yu, J | 1 |
| Gao, L | 1 |
| Du, L | 1 |
| Zhu, D | 1 |
| Wu, S | 1 |
| Pan, J | 1 |
| Yang, L | 1 |
| Chen, Q | 1 |
| Wang, P | 1 |
| Tang, R | 1 |
| Huang, X | 1 |
| Chen, X | 1 |
| Szczuko, M | 1 |
| Zapalowska-Chwyć, M | 1 |
| Drozd, R | 1 |
| Katsiki, N | 1 |
| Athyros, VG | 1 |
| Karagiannis, A | 1 |
| Mikhailidis, DP | 1 |
| Márquez, JL | 1 |
| Pacheco, A | 1 |
| Valdés, P | 1 |
| Salazar, LA | 1 |
| Macut, D | 1 |
| Simic, T | 1 |
| Lissounov, A | 1 |
| Pljesa-Ercegovac, M | 1 |
| Bozic, I | 1 |
| Djukic, T | 1 |
| Bjekic-Macut, J | 1 |
| Matic, M | 1 |
| Petakov, M | 1 |
| Suvakov, S | 1 |
| Damjanovic, S | 1 |
| Savic-Radojevic, A | 1 |
| Luque-Ramírez, M | 1 |
| Alvarez-Blasco, F | 1 |
| Uriol Rivera, MG | 1 |
| Escobar-Morreale, HF | 1 |
| Anttila, L | 1 |
| Rouru, J | 1 |
| Penttilä, T | 1 |
| Irjala, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Data-driven Clustering for Metabolic Classification of Obesity Using Machine Learning[NCT04282837] | 2,495 participants (Actual) | Observational | 2020-03-01 | Completed | |||
| The Cardiovascular Risk Profile Associated With The Polycystic Ovary Syndrome And With Ovulatory Hyperandrogenism, And Its Changes During Treatment With Metformin Or Oral Contraceptives[NCT00428311] | Phase 4 | 50 participants | Interventional | 2004-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for uric acid and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
The Associations Between Alanine Aminotransferase and Other Biochemical Parameters in Lean PCOS.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Body Mass Index; Female; Humans; Polycystic Ovary | 2023 |
Uric acid metabolism in polycystic ovary syndrome.
Topics: Female; Humans; Hyperuricemia; Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrome; Ur | 2021 |
Uric acid participating in female reproductive disorders: a review.
Topics: Amniotic Fluid; Endometriosis; Female; Fetal Growth Retardation; Gonadal Steroid Hormones; Humans; I | 2021 |
Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.
Topics: Endothelium, Vascular; Female; Humans; Hypertriglyceridemia; Lipoproteins, HDL; Lipoproteins, LDL; L | 2014 |
2 trials available for uric acid and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Insulin resistance in non-obese women with polycystic ovary syndrome: relation to byproducts of oxidative stress.
Topics: Adult; Antioxidants; Body Mass Index; Female; Humans; Insulin Resistance; Malondialdehyde; Oxidative | 2011 |
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Topics: Adolescent; Adult; Body Mass Index; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; | 2008 |
17 other studies available for uric acid and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Neck Circumference Is Associated With Hyperuricemia in Women With Polycystic Ovary Syndrome.
Topics: Adult; Anthropometry; Body Mass Index; Cross-Sectional Studies; Female; Humans; Hyperuricemia; Neck; | 2021 |
Correlation Between Serum Uric Acid and Body Fat Distribution in Patients With Polycystic Ovary Syndrome.
Topics: Absorptiometry, Photon; Adipose Tissue; Adult; Body Fat Distribution; Female; Humans; Hyperuricemia; | 2021 |
Effects of a ketogenic diet in women with PCOS with different uric acid concentrations: a prospective cohort study.
Topics: Body Mass Index; Diet, Ketogenic; Female; Humans; Obesity; Overweight; Polycystic Ovary Syndrome; Pr | 2022 |
Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Body Mass Index; Case- | 2022 |
Analysis of HIF2α polymorphisms in infertile women with polycystic ovary syndrome or unexplained infertility.
Topics: Blood Glucose; C-Reactive Protein; Female; Humans; Infertility, Female; Insulins; Lipids; Polycystic | 2022 |
Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study.
Topics: Birth Weight; Embryo Transfer; Female; Fertilization in Vitro; Humans; Live Birth; Male; Polycystic | 2023 |
Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study.
Topics: Birth Weight; Embryo Transfer; Female; Fertilization in Vitro; Humans; Live Birth; Male; Polycystic | 2023 |
Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study.
Topics: Birth Weight; Embryo Transfer; Female; Fertilization in Vitro; Humans; Live Birth; Male; Polycystic | 2023 |
Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study.
Topics: Birth Weight; Embryo Transfer; Female; Fertilization in Vitro; Humans; Live Birth; Male; Polycystic | 2023 |
Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study.
Topics: Birth Weight; Embryo Transfer; Female; Fertilization in Vitro; Humans; Live Birth; Male; Polycystic | 2023 |
Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study.
Topics: Birth Weight; Embryo Transfer; Female; Fertilization in Vitro; Humans; Live Birth; Male; Polycystic | 2023 |
Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study.
Topics: Birth Weight; Embryo Transfer; Female; Fertilization in Vitro; Humans; Live Birth; Male; Polycystic | 2023 |
Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study.
Topics: Birth Weight; Embryo Transfer; Female; Fertilization in Vitro; Humans; Live Birth; Male; Polycystic | 2023 |
Elevated serum uric acid level is associated with adverse reproductive outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycles: a retrospective cohort study.
Topics: Birth Weight; Embryo Transfer; Female; Fertilization in Vitro; Humans; Live Birth; Male; Polycystic | 2023 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Serum uric acid/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women.
Topics: Androgens; Blood Glucose; Body Mass Index; Creatinine; Estradiol; Female; Follicle Stimulating Hormo | 2022 |
Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.
Topics: Androgens; Body Mass Index; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Disease | 2023 |
The Impact of Atorvastatin on Cardiometabolic Risk Factors in Sisters of Women with Polycystic Ovary Syndrome.
Topics: Androgens; Atorvastatin; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; | 2023 |
Evaluation of renal disturbance in animal models of polycystic ovary syndrome.
Topics: Animals; Creatinine; Female; Kidney; Models, Animal; Polycystic Ovary Syndrome; Rats; Rats, Wistar; | 2023 |
Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid-a familiar foe.
Topics: Animals; Female; Letrozole; Liver; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Spironolact | 2020 |
The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome.
Topics: Adult; Aged; Androgens; Anticholesteremic Agents; Atorvastatin; Blood Glucose; C-Reactive Protein; C | 2021 |
Machine Learning to Identify Metabolic Subtypes of Obesity: A Multi-Center Study.
Topics: Adult; Blood Glucose; Body Mass Index; China; Comorbidity; Female; Glucose Tolerance Test; Humans; H | 2021 |
Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome.
Topics: Adult; Body Mass Index; China; Cross-Sectional Studies; Estradiol; Female; Follicle Stimulating Horm | 2018 |
A Low Glycemic Index Decreases Inflammation by Increasing the Concentration of Uric Acid and the Activity of Glutathione Peroxidase (GPx3) in Patients with Polycystic Ovary Syndrome (PCOS).
Topics: Adult; Female; Glutathione Peroxidase; Glycemic Index; Humans; Inflammation; Polycystic Ovary Syndro | 2019 |
Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women.
Topics: Adolescent; Adult; Alleles; Blood Glucose; Calpain; Chile; Cholesterol; Cholesterol, LDL; DNA; Femal | 2008 |
Normal serum uric acid concentrations in women with polycystic ovary syndrome.
Topics: Adult; Androstenedione; Body Mass Index; Female; Humans; Insulin; Insulin Resistance; Luteinizing Ho | 1996 |